Minerva Neurosciences (NERV) Non-Current Deferred Tax Liability (2013 - 2021)

Minerva Neurosciences has reported Non-Current Deferred Tax Liability for 9 years, with the latest figure at $1.8 million in Q3 2021.

• For the quarter ending Q3 2021, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $1.8 million; the trailing twelve-month figure through Sep 2021 stood at $1.8 million (changed 0.0% YoY), and the FY2020 full-year result was $1.8 million, changed 0.0% from the prior year.
• Non-Current Deferred Tax Liability for Q3 2021 stood at $1.8 million, roughly flat from $1.8 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $13.4 million in Q1 2017, with the low at $1.8 million in Q4 2019.
• Historically, Non-Current Deferred Tax Liability has averaged $4.6 million across 5 years, with a median of $4.1 million in 2017.
• The largest YoY upside for Non-Current Deferred Tax Liability was 0.0% in 2017 against a maximum downside of 69.8% in 2017.
• Minerva Neurosciences' Non-Current Deferred Tax Liability stood at $4.1 million in 2017, then changed by 0.0% to $4.1 million in 2018, then slumped by 55.55% to $1.8 million in 2019, then changed by 0.0% to $1.8 million in 2020, then changed by 0.0% to $1.8 million in 2021.
• The last three Non-Current Deferred Tax Liability figures came in at $1.8 million (Q3 2021), $1.8 million (Q2 2021), and $1.8 million (Q1 2021), per Business Quant data.